Shorter effective tripeptides (e.g. Ac‐QAW) also generated promising proof‐of‐concept data, inhibiting the growth of human colon cancer xerograph (via modulation of NF‐κB activation) and reducing postoperative neuroinflammation and cognitive changes in cardiopulmonary bypass (Zhang, Ma, et al., 2017). This evidence concerns the gene NFKB1 and malignant colon neoplasm.